DIFLUPREDNATE 0.05%w/v IP + SORBIC ACID 0.1%v/v IP

A topical ocular corticosteroid is used for the treatment of inflammation and pain associated with ocular surgery. (Palacio-Pastrana C, 2020) A potent ophthalmic steroid with high potency, a favorable safety profile, and the ability to reduce postoperative pain. (Callanan, 2009) Stops the release of certain natural substances in the eye responsible for pain and inflammation (redness and swelling). (Bijnya B Panda, 2021) Shows rapid resolution of both inflammation and pain associated with ocular surgery. An effective agent that controls anterior segment inflammation and reduction of cystoid macular edema in patients with uveitis. (Mark A Slabaugh, 2012) Clears postoperative inflammation and reduces pain rapidly and effectively. Provides a convenient option for managing ocular inflammation, relieves pain and discomfort postoperatively. A welcome addition to the available topical steroid options to manage inflammatory response after cataract surgery. Effectively reduces postoperative inflammation and decreases corneal edema and retinal thickness. (Kusne Y, 2016)